Survival Benefit of Early Infant Antiretroviral Therapy is Compromised When Diagnosis is Delayed
暂无分享,去创建一个
B. Richardson | G. John-Stewart | D. Wamalwa | J. Slyker | K. Tapia | S. Benki-Nugent | A. Langat | E. Ngugi | Agnes Langat
[1] M. Egger,et al. Early Mortality and Loss to Follow-up in HIV-Infected Children Starting Antiretroviral Therapy in Southern Africa , 2010, Journal of acquired immune deficiency syndromes.
[2] P. Novosad,et al. Early Clinical Outcomes in Children Enrolled in Human Immunodeficiency Virus Infection Care and Treatment in Lesotho , 2009, The Pediatric infectious disease journal.
[3] J. Stockman. Early Antiretroviral Therapy and Mortality among HIV-Infected Infants , 2010 .
[4] Z. Gizlice,et al. Mortality and Associated Factors After Initiation of Pediatric Antiretroviral Treatment in the Democratic Republic of the Congo , 2009, The Pediatric infectious disease journal.
[5] Victor Segalen Bordeaux,et al. Low Risk of Death, but Substantial Program Attrition, in Pediatric HIV Treatment Cohorts in Sub-Saharan Africa , 2008, Journal of acquired immune deficiency syndromes.
[6] James A McIntyre,et al. Early antiretroviral therapy and mortality among HIV-infected infants. , 2008, The New England journal of medicine.
[7] B. Chi,et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. , 2007, JAMA.
[8] J. Overbaugh,et al. Early Response to Highly Active Antiretroviral Therapy in HIV-1-Infected Kenyan Children , 2007, Journal of acquired immune deficiency syndromes.
[9] B. Eley,et al. Antiretroviral treatment for children. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[10] J. Overbaugh,et al. Predictors of Early Mortality in a Cohort of Human Immunodeficiency Virus Type 1-Infected African Children , 2004, The Pediatric infectious disease journal.